First large-scale malaria vaccine trials for Africa

malaria vaccine

MALARIA VACCINE TRIALS. A child suffering from malaria lies on a bed at the hospital of Nyarugusu, in north west of Tanzania, on June 11, 2015. AFP PHOTO/STEPHANIE AGLIETTI

The vaccine, also known as Mosquirix, is developed by GlaxoSmithKline (GSK) in partnership with the PATH Malaria Vaccine Initiative. The large-scale three-country pilot will test it on children aged 5 to 17 months

NAIROBI, Kenya (Apr. 24, 2017) — A new malaria vaccine will be tested on a large scale in Kenya, Ghana and Malawi, the World Health Organization said Monday, April 24, with 360,000 children to be vaccinated between 2018 and 2020. Continue reading